Fundraising Fox

TherapeuticsMD

NASDAQ: TXMD

Boca Raton, US · Nevada corporation

Biotech

Founders & leadership

RG
Robert G. FinizioFounder
MD
Michael DoneganExecutive
JC
John C.K. Milligan, IVExecutive
EB
Edward BorkowskiExecutive
JC
James C. D'AreccaExecutive

Board

CC
Cooper CollinsBoard director
JM
J. Martin CarrollBoard director
AC
Angus C. RussellBoard director
KL
Karen L. LingBoard director
JA
Jules A. MusingBoard director
PM
Paul M. BisaroBoard director
TG
Tommy G. ThompsonBoard director

Reported raises · per SEC filings

Form D private placements

$37.6M disclosed across 5 rounds · 2020–2023

▶$1.1MraisedJul 2023 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Tommy G. ThompsonDirector
  • Justin RobertsDirector
  • Marlan WalkerExecutive Officer
  • Michael C. DoneganExecutive Officer
  • Gail NaughtonDirector
  • Cooper C. CollinsDirector
Offering amount
$5M
Amount sold
$1.1M
First sale
Jun 2023
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedNov 2022 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian BernickExecutive Officer
  • Gail NaughtonDirector
  • Jules A. MusingDirector
  • Justin RobertsDirector
  • Tommy G. ThompsonDirector
  • Mark GlickmanExecutive Officer
  • Karen LingDirector
  • Paul BisaroDirector
  • Michael C. DoneganExecutive Officer
  • Marlan WalkerExecutive Officer
  • Cooper CollinsDirector
  • Angus C. RussellDirector
Offering amount
$7M
Amount sold
$7M
Sales commissions
$350K
Placement agents
Greenhill & Co. LLC
First sale
Oct 2022
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedOct 2022 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Cooper CollinsDirector
  • Angus C. RussellDirector
  • Karen LingDirector
  • Marlan WalkerExecutive Officer
  • Paul BisaroDirector
  • Mark GlickmanExecutive Officer
  • Michael C. DoneganExecutive Officer
  • Tommy G. ThompsonDirector
  • Jules A. MusingDirector
  • Gail NaughtonDirector
  • Brian BernickExecutive Officer
  • Justin RobertsDirector
Offering amount
$7M
Amount sold
$7M
Sales commissions
$350K
Placement agents
Greenhill & Co. LLC
First sale
Sep 2022
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedAug 2022 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Karen LingDirector
  • Gail NaughtonDirector
  • Hugh O'DowdExecutive Officer, Director
  • Marlan WalkerExecutive Officer
  • Michael C. DoneganExecutive Officer
  • Mark GlickmanExecutive Officer
  • Paul BisaroDirector
  • Cooper CollinsDirector
  • Angus C. RussellDirector
  • Jules A. MusingDirector
  • Tommy G. ThompsonDirector
Offering amount
$15M
Amount sold
$15M
Sales commissions
$750K
Placement agents
Greenhill & Co. LLC
First sale
Jul 2022
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.5MraisedAug 2020 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael DoneganExecutive Officer
  • Cooper C. CollinsDirector
  • John C.K. Milligan, IVExecutive Officer
  • J. Martin CarrollDirector
  • Angus C. RussellDirector
  • Edward BorkowskiExecutive Officer
  • Karen L. LingDirector
  • Robert G. FinizioExecutive Officer, Director
  • James C. D'AreccaExecutive Officer
  • Jules A. MusingDirector
  • Paul M. BisaroDirector
  • Tommy G. ThompsonDirector
  • Gail K. NaughtonDirector
  • Marlan D. WalkerExecutive Officer
Offering amount
$7.5M
Amount sold
$7.5M
First sale
Aug 2020
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Form 10-Q TherapeuticsMD, Inc. For: Jun 30streetinsider.com · Aug 2026TherapeuticsMD posts modest profit amid going‑concern risks | TXMD Quarterly Report (10-Q)stocktitan.net · Aug 2026TherapeuticsMD Raises Investor Interest With New Earnings Report | Investing.cominvesting.com · Nov 2017

Frequently asked questions

Who founded TherapeuticsMD?
TherapeuticsMD was founded by Robert G. Finizio.
How much funding has TherapeuticsMD raised?
TherapeuticsMD has disclosed $37.6M raised across 5 rounds.
Where is TherapeuticsMD headquartered?
TherapeuticsMD is headquartered in Boca Raton, US.